FACULTY AFFILIATIONS
| |
|
|
|
 |
Charles L Vogel, MD
Medical Director
Cancer Research Network Inc
Plantation, Florida |
 |
G Thomas Budd, MD
Professor of Medicine
Cleveland Clinic Lerner College
of Medicine of Case Western
Reserve University
Cleveland Clinic Foundation
Cleveland, Ohio |
| |
|
|
|
 |
Alisha Stein, RNC, BSN, OCN
CNS/Research Coordinator
Cancer Research Network Inc
Plantation, Florida |
 |
Desiree Grogan, RPA-C
Cancer Institute of Long Island
Great Neck, New York |
CONTENT VALIDATION AND DISCLOSURES
Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and
other individuals who are in a position to control the content of CNE activities. All relevant conflicts of interest that
are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity,
and patient care recommendations. PIM is committed to providing its learners with high-quality CNE activities
and related materials that promote improvements or quality in healthcare and not a specific proprietary business
interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their
spouse/life partner have with commercial interests related to the content of this CNE activity:
Dr Vogel — Consulting Fees: Amgen Inc, AstraZeneca Pharmaceuticals LP, Biomira Inc, Cancer International Research Group
(BCIRG), Genentech BioOncology, GlaxoSmithKline, Ortho Biotech Products LP, Pfizer Inc, Sanofi-Aventis, Tibotec Inc; Speakers
Bureau: Amgen Inc, AstraZeneca Pharmaceuticals LP, Biomira Inc, Bristol-Myers Squibb Company, Eli Lilly and Company,
Genentech BioOncology, GlaxoSmithKline, Novartis Pharmaceuticals, Ortho Biotech Products LP, Pfizer Inc, Pierre-Fabre
Pharmaceuticals Inc, Roche Laboratories Inc, Sanofi-Aventis, Tibotec Inc; Contracted Research: Amgen Inc, AstraZeneca
Pharmaceuticals LP, Biomira Inc, Bristol-Myers Squibb Company, Cancer International Research Group (BCIRG), Eisai Inc,
Eli Lilly and Company, Genentech BioOncology, GlaxoSmithKline, Novartis Pharmaceuticals, NSABP, Ortho Biotech Products
LP, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis, Taiho Pharmaceutical Co Ltd, Tibotec Inc. Ms Stein — Fees for Non-CME Services Received Directly from Commercial Interest or Their Agents: Amgen Inc. Dr Budd — Consulting Fees: Amgen
Inc, Exagen Diagnostics, Pfizer Inc; Contracted Research: Abbott Laboratories, AstraZeneca Pharmaceuticals LP, Immunicon
Corporation, Johnson & Johnson Pharmaceuticals, Pfizer Inc, Wyeth. Ms Grogan — Consulting Fees: Amgen Inc.
The planners and managers reported the following financial relationships or relationships to products or devices
they or their spouse/life partner have with commercial interests related to the content of this CNE activity:
Richard Kaderman, PhD, Neil Love, MD, Douglas Paley, Margaret Peng, Lilliam Sklaver Poltorack, PharmD, Ginelle
Suarez, Erin Wall and Kathryn Ault Ziel, PhD — no real or apparent conflicts of interest to report; Sally Bogert, RNC,
WHCNP — shareholder of Amgen Inc. Research To Practice receives education grants from Abraxis Oncology,
Amgen Inc, AstraZeneca Pharmaceuticals LP, Bayer Pharmaceuticals Corporation/Onyx Pharmaceuticals Inc,
Genentech BioOncology/OSI Pharmaceuticals Inc, Genomic Health Inc, Roche Laboratories Inc and Sanofi-
Aventis, who have no influence on the content development of our educational activities.
The following PIM clinical content reviewers, Jan Hixon, RN, Linda Graham, RN and Trace Hutchison, PharmD, state
that they or their spouse/life partner do not have any financial relationships or relationships to products or devices
with any commercial interests related to the content of this CNE activity of any amount during the past 12 months.
This educational activity may contain discussion of published and/or investigational uses of agents that are
not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Research To Practice, Abraxis Oncology,
AstraZeneca Pharmaceuticals LP, Genentech BioOncology and Genomic Health Inc do not recommend the use of
any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the
views of PIM, Research To Practice, Abraxis Oncology, AstraZeneca Pharmaceuticals LP, Genentech BioOncology or
Genomic Health Inc. Please refer to the official prescribing information for each product for discussion of approved
indications, contraindications and warnings.
